FDA Inspection 1209601 — Janssen Research And Development, LLC
The FDA completed an inspection of Janssen Research And Development, LLC on Jun 16, 2023 in Somerville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 16, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somerville, NJ (United States)
Additional details
Sponsor, Contract Research Organization